Error-enhanced Learning & Recovery in 2 & 3 Dimensions

October 22, 2024 updated by: James Lanphier Patton, Shirley Ryan AbilityLab
This study is being done to see how errors lead to improvement. Specifically, we are evaluating the errors stroke participants make during an upper extremity exercise program when reaching for a target using their affected arm. Once we understand the participant's reaching errors, we plan to create a customized reaching exercise according to the individual's specific error tendencies which will lead to better performance on movement ability after training.

Study Overview

Detailed Description

The neuroplasticity of motor re-learning is a key pathway for recovery in neurorehabilitation. One critical challenge to devising treatment plans for motor recovery is the wide variation that exists between individuals, across movement repetitions, and even within movements. Development of a learning model that looks at these factors would better relate diagnoses to treatments, providing personalization and efficiency to therapy. This proposal aims to advance rehabilitation by building a modeling framework that explores the trends and exploits a fundamental learning process - error. Our goal is to preliminarily test the direct effect of this new treatment in preparation for the randomized controlled study to come. Understanding how error leads to better performance will help us program future devices for therapy for optimal outcomes.

We are using research lab equipment at the Shirley Ryan AbilityLab (SRALab) Hospital's Robotics group. The equipment will be used to implement the reaching exercises and measure participant movement. The equipment includes:

  1. Barret b.u.r.t. arm robot with Teneo forearm attachment
  2. LookingGlass virtual reality display system
  3. Garmin Venu Sq fitness tracking wristwatch

Study Outline:

Week 1, Visit 1: Consent, In-Person Screening, and Baseline Evaluations Participants will sign a consent form. Then, they will undergo a screening process to check if they meet all the eligibility requirements. Participants that pass the in-person screening and agree to continue with the study will complete baseline evaluations which will consistent of upper extremity outcome measures, and a preliminary reaching experiment on the b.u.r.t. robotic arm.

Weeks 2-3, Visits 2-7: Treatment Visits In the following two weeks, participants will come to the lab three times a week. They will use the robotic arm, and complete several rounds of reaching exercises while looking in the virtual reality display system. Depending on the treatment visit, participants will either take home a fitness tracker, or be asked to return it.

Week 4, Visit 8: Post-Evaluations About a week after the treatment sessions, participants will return to the lab and complete the same evaluations they completed during visit 1 to see if there is any change.

Weeks 5-8: There will be no lab visits during this time.

Week 9, Visit 9: About 5-6 weeks after the treatment visits, participants will come back for follow-up evaluations. These will be the same outcome measures completed during the baseline and post-evaluation sessions.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Naveed Aghamohammadi
  • Phone Number: 7654215544
  • Email: nagham2@uic.edu

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Recruiting
        • Shirley Ryan AbilityLab
        • Contact:
          • Courtney Celian, MS
        • Principal Investigator:
          • James Patton, PhD
      • Chicago, Illinois, United States, 60611
        • Recruiting
        • Shirley Ryan AbilityLab (Healthy Participants)
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. 18 years of age or older
  2. Chronic stroke (8+ months post stroke event) with primary motor cortex involvement
  3. Hemiparesis
  4. Some degree of both shoulder and elbow movement capability

Exclusion Criteria:

  1. Bilateral paresis
  2. Severe tactile deficits using the Two-Point Discrimination Test (participant must detect<11mm)
  3. Severe proprioceptive deficits
  4. Severe spasticity (Modified Ashworth >3) preventing movement
  5. Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment
  6. Visual deficits, and hemispatial neglect that would prevent the subjects from seeing the targets.
  7. Inability to provide an informed consent
  8. severe current medical problems
  9. diffuse/multiple lesion sites or multiple stroke events
  10. Inability to attain and maintain testing positions
  11. Botox injection to the affected upper extremity within the previous 4 months
  12. Concurrent participation in upper extremity rehabilitation either as part of a research intervention protocol or a prescribed therapy
  13. Participation in previous, similar robotics intervention study
  14. Other neurological issues

None of the following special populations will be included in this research study:

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Vulnerable Populations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Group 1
Participants will complete a reaching experiment using the robotic arm with error fields turned on.
Participants will complete a reaching experiment using the robotic arm with error fields turned off.
Other: Group 2
Participants will complete a reaching experiment using the robotic arm with error fields turned on.
Participants will complete a reaching experiment using the robotic arm with error fields turned off.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Perpendicular Error
Time Frame: 60-90 minutes
60-90 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
Action Research Arm Test
Time Frame: 5-20 minutes
5-20 minutes

Other Outcome Measures

Outcome Measure
Time Frame
Upper Extremity portion of the Fugl-Meyer
Time Frame: 5-20 minutes
5-20 minutes
Box and Blocks
Time Frame: 5-20 minutes
5-20 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James Patton, PhD, Shirley Ryan AbilityLab

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Estimated)

December 30, 2025

Study Completion (Estimated)

December 30, 2025

Study Registration Dates

First Submitted

November 4, 2021

First Submitted That Met QC Criteria

December 17, 2021

First Posted (Actual)

January 6, 2022

Study Record Updates

Last Update Posted (Actual)

October 24, 2024

Last Update Submitted That Met QC Criteria

October 22, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Error Fields

Subscribe